CVS Health Raises 2026 Guidance and Declares Dividend Following Revenue Beat

Key Facts

1CVS Health declared a quarterly dividend of USD 0.665 per share.

2Second quarter revenue increased by 7.30% to USD 106.10 billion, beating analyst estimates.

3The company raised its fiscal 2026 adjusted earnings guidance, indicating a recovery across business segments.

CVS Health declared a quarterly cash dividend of $0.665 per share, payable on November 2, 2026, to shareholders of record as of October 22. AD HOC NEWS reported that second-quarter revenue increased by 7.30% to $106.10 billion, exceeding analyst estimates, while adjusted earnings per share rose 42.50% to reach $2.58.

The company raised its fiscal 2026 adjusted earnings guidance to a range of $7.90 to $8.10 per share, up from its previous outlook. CVS closed at $85.2 on October 1, 2026, as Cantor Fitzgerald reiterated an Overweight rating on the stock with a $110 price target in a report dated October 1, 2026.